As of 2025-10-21, the Relative Valuation of Bristol-Myers Squibb Co (BMY) is 51.61 USD. This relative valuation is based on P/E multiples. With the latest stock price at 43.59 USD, the upside of Bristol-Myers Squibb Co based on Relative Valuation is 18.4%.
The range of the Relative Valuation is 50.02 - 66.39 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 20.2x - 26.8x | 20.8x |
| Fair Price | 50.02 - 66.39 | 51.61 |
| Upside | 14.7% - 52.3% | 18.4% |
| Date | P/E |